GH
Guardant Health Inc
NASDAQ: GH · HEALTHCARE · DIAGNOSTICS & RESEARCH
$83.41
+0.39% today
Updated 2026-04-29
Market cap
$11.06B
P/E ratio
—
P/S ratio
11.26x
EPS (TTM)
$-3.32
Dividend yield
—
52W range
$36 – $121
Volume
2.0M
Guardant Health Inc (GH) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-36.71M | $-72.23M | $-72.19M | $-47.13M | $-103.93M | $-209.02M | $-309.46M | $-324.98M | $-239.86M | $-184.76M |
| Capital expenditures | $1.77M | $8.98M | $20.20M | $21.29M | $54.06M | $75.03M | $77.46M | $20.49M | $35.09M | $48.31M |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.97M | $3.67M | $6.85M | $16.95M | $144.11M | $151.45M | $94.69M | $90.76M | $140.41M | $166.22M |
| Free cash flow | $-38.48M | $-81.22M | $-92.39M | $-68.42M | $-157.99M | $-284.05M | $-386.92M | $-345.46M | $-274.94M | $-233.07M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $3.16M | — | $7.09M | $17.86M | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $67.95M | $2.60M | $689.29M | $-339.00M | $-348.74M | — | — | — |